Bumper Offer - Urjas oil Just @ Rs. 1 X
Glyrep 500 Tablet SR is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Diabetes.
The optimal dosage of Glyrep 500 Tablet SR is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Glyrep 500 Tablet SR also has some side effects, the most common being Stomach Upset, Difficulty urinating. Some other side effects of Glyrep 500 Tablet SR have been listed ahead. Usually, these side effects of Glyrep 500 Tablet SR go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Glyrep 500 Tablet SR is Mild for pregnant women and Moderate for women who are breastfeeding. It is important to know if Glyrep 500 Tablet SR has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Glyrep 500 Tablet SR related warnings section.
Individuals suffering from medical conditions like Congestive Heart Failure (CHF), Anemia, Shock must refrain from the use of Glyrep 500 Tablet SR since this can cause severe adverse effects. Some other conditions that can be affected by Glyrep 500 Tablet SR are listed in the contraindications section below.
Drug interactions for Glyrep 500 Tablet SR have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Glyrep 500 Tablet SR is safe while driving, and is is addictive in nature.
Glyrep 500 Tablet SR is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Glyrep 500 Tablet SR is used -
Severe
Moderate
Mild
Common
Is the use of Glyrep 500 Tablet SR safe for pregnant women?
Pregnant women may get mild side effects from Glyrep.
Is the use of Glyrep 500 Tablet SR safe during breastfeeding?
Breastfeeding women may feel side effects of Glyrep. If you see any side effects, stop taking Glyrep immediately and talk to your doctor. Take Glyrep again, only after your doctor's advice.
What is the effect of Glyrep 500 Tablet SR on the Kidneys?
Glyrep does not damage the kidneys.
What is the effect of Glyrep 500 Tablet SR on the Liver?
Glyrep is completely safe for the liver.
What is the effect of Glyrep 500 Tablet SR on the Heart?
Glyrep is completely safe for the heart.
Glyrep 500 Tablet SR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glyrep 500 Tablet SR unless your doctor advises you to do so -
Is this Glyrep 500 Tablet SR habit forming or addictive?
No, there is no any evidence that Glyrep 500 Tablet SR is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Glyrep 500 Tablet SR since it will not make you feel sleepy.
Is it safe?
Glyrep 500 Tablet SR should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Glyrep 500 Tablet SR in mental disorders is not effective.
Interaction between Food and Glyrep 500 Tablet SR
Due to a lack of research, nothing can be said about the consequences of taking Glyrep 500 Tablet SR together with food.
Interaction between Alcohol and Glyrep 500 Tablet SR
Taking alcohol with Glyrep 500 Tablet SR can be dangerous.
Glyrep increases the sensitivity of insulin, young women with PCOS often have elevated insulin levels and are more likely to develop diabetes. It is often prescribed for women with PCOS to help prevent diabetes. A lifestyle that includes healthy nutrition and daily exercise is the most important part of a PCOS treatment plan.
Glyrep is not a known cause of alopecia (hair loss). However, the conditions treated by Glyrep type 2 diabetes and PCOS, often list hair loss as a possible symptom.
Yes, you can take Glyrep with a beta-blocker. People with diabetes tend to develop heart disease or stroke at an earlier age than the general population. One reason for this is that high glucose levels increase your risk of high blood pressure (hypertension). No harmful interactions are seen between them. However, a recent study suggests that beta-blockers can decrease the plasma level of Glyrep and long-term use can increase lactic acid and uric acid in the blood.
Glyrep is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
Yes, Glyrep can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Glyrep causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Glyrep may need to be adjusted.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826